Tech Company Financing Transactions
Checkmate Pharmaceuticals Funding Round
Checkmate Pharmaceuticals, based in Cambridge, raised $20 million from Sofinnova Ventures and venBio.
Transaction Overview
Company Name
Announced On
8/13/2015
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
These funds will further enable the company to develop additional generations of oligonucleotide-based products in the field of immuno-oncology.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
245 Main St. 2nd Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Checkmate Pharma is developing a new approach for cancer immunotherapy, by specifically activating the immune system to recognize and kill tumor cells throughout the body, without harming normal tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Labinger
Chief Financial Officer
Jon Lieber
Chief Medical Officer
James Wooldridge
Chief Operating Officer
Karen Brennan
Chief Scientific Officer
Art Krieg
VP - Bus. Development
Kleem Chaudhary
VP - General Counsel
Chuck Yon
VP - Operations
Lisa White
VP - Regulatory Affairs
Chris French
VP - Regulatory Affairs
Steven Hamburger
Browse more venture capital transactions:
Prev: 8/13/2015: Arbor Plastic Technologies venture capital transaction
Next: 8/13/2015: Front Row Education venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs